AstraZeneca

News

Pieris wields axe after losing AZ as partner for elarekibep

AstraZeneca has terminated a partnership with Pieris Pharmaceuticals on respiratory drug candidate elarekibep, forcing the latter to slash staff and look into its “strateg

News

Beyfortus cleared by FDA for RSV prevention in infants

Sanofi’s plan to become a dominant player in the respiratory syncytial virus (RSV) market has moved a step closer, with FDA approval of Beyfortus for the prevention of RSV

News

AZ, Daiichi’s TROP2 drug hits the mark in lung cancer

AstraZeneca and partner Daiichi Sankyo have their first phase 3 data for TROP2-targeting antibody-drug conjugate (ADC) datopotamab deruxtecan (Dato-DXd) – in lung cancer –

Oncology

Oncology 2023

Oncology 2023 features interviews, analysis, and commentary from pharmaphorum, industry leaders, and more

News

AstraZeneca pledges $400m to fight deforestation

AstraZeneca has said it will plant 200 million trees across six continents by 2030 in an effort to fight escalating rates of deforestation around the globe that is contrib

News

AZ may spin off its Chinese business, says report

AstraZeneca is looking at spinning out its Chinese operation and listing it in Hong Kong or Shanghai to insulate the business from rising geopolitical tension, according t

Pieris wields axe after losing AZ as partner for elarekibep

Beyfortus cleared by FDA for RSV prevention in infants

AZ, Daiichi’s TROP2 drug hits the mark in lung cancer

Oncology 2023

AstraZeneca pledges $400m to fight deforestation

AZ may spin off its Chinese business, says report

Kyverna builds case for CAR-T in stiff person syndrome

Discover a new era of healthcare panel engagement: Grounded ...

AstraZeneca

Editor's Picks